A randomised controlled trial of treatments of childhood anxiety disorder in the context of maternal anxiety disorder: clinical and cost-effectiveness outcomes
Autor: | Roz Shafran, Emma McIntosh, Mara Violato, Cathy Creswell, Lucy Willetts, Peter J. Cooper, Susan Cruddace, Stephen Gerry, Lynne Murray, Alan Stein |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male Pediatrics medicine.medical_specialty parent–child interaction Cost effectiveness Cost-Benefit Analysis Psychological intervention Mothers Context (language use) law.invention 03 medical and health sciences 0302 clinical medicine Child of Impaired Parents Randomized controlled trial law Outcome Assessment Health Care Developmental and Educational Psychology medicine Humans 0501 psychology and cognitive sciences Child Cognitive Behavioral Therapy cognitive behaviour therapy mother 05 social sciences Original Articles anxiety medicine.disease Anxiety Disorders Mother-Child Relations 3. Good health Quality-adjusted life year Psychiatry and Mental health Pediatrics Perinatology and Child Health Anxiety Female Original Article Maternal anxiety medicine.symptom Psychology 030217 neurology & neurosurgery Anxiety disorder 050104 developmental & child psychology |
Zdroj: | Journal of Child Psychology and Psychiatry, and Allied Disciplines |
ISSN: | 1469-7610 0021-9630 |
Popis: | Background: This study evaluated whether clinical and economic outcomes from CBT for child anxiety disorders in the context of maternal anxiety disorders are improved by adding treatment focused on (i) maternal anxiety disorders, or (ii) mother-child interactions. Methods: 211 children (7 – 12 years, 85% White British, 52% female) with a primary anxiety disorder, whose mothers also had a current anxiety disorder, were randomised to receive (i) child-focused CBT with non-specific control interventions (CCBT+Con), (ii) CCBT with CBT for the maternal anxiety disorder (CCBT+MCBT), or (iii) CCBT with an intervention targeting the mother-child interaction (CCBT+MCI). A cost-utility analysis from a societal perspective was conducted using mother/child combined Quality Adjusted Life Years (QALYs). [Trial registration: https://doi.org/10.1186/ISRCTN19762288]. Results: MCBT was associated with immediate reductions in maternal anxiety compared to the non-specific control; however, after children had also received CCBT, maternal outcomes in the CCBT+MCI and CCBT+Con arms improved and CCBT+MCBT was no longer superior. Neither CCBT+MCBT nor CCBT+MCI conferred a benefit over CCBT+Con in terms of child anxiety disorder diagnoses post-treatment [primary outcome] (adj RR: 1.22 (95% CI 0.88, 1.67), p = .23; adj RR: 1.21 (95% CI 0.88, 1.65), p = .24 respectively) or global improvement ratings (adj RR 1.25 (95% CI 0.99, 1.57), p = .06; adj RR 1.18 (95% CI 0.93, 1.50), p = .17) or six and 12 months later. No significant differences between the groups were found on the main economic outcome measures (child/mother combined QALY mean difference: CCBT+MCBT vs CCBT+Con: -0.04 (95% CI -0.12, 0.04), p = 0.29; CCBT+MCI vs CCBT+Con: 0.02 (95% CI -0.05, -0.09), p = 0.54). CCBT+MCI was associated with non-significantly higher costs than CCBT (mean difference: £154 (95% CI -£1239, £1547), p = 0.83) but, when taking into account sampling uncertainty, it may be cost-effective compared with CCBT alone. Conclusions: Good outcomes were achieved for children and their mothers across treatment arms. There was no evidence of significant clinical benefit from supplementing CCBT with either CBT for the maternal anxiety disorder or treatment focussed on mother-child interactions, but the addition of MCI (and not MCBT) may be cost-effective. Keywords: Child; anxiety; mother; parent-child interaction; CBT. |
Databáze: | OpenAIRE |
Externí odkaz: |